Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

Yutao Guo; Hang Zhu; Yundai Chen; Professor Gregory Lip

doi:10.1016/j.amjmed.2017.09.009

Back

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

Article 2017 en

Related publications

Article2017

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Alena Shantsila, Vanessa Roldán, Professor Gregory Lip, Francisco Marı́n

Article2022

Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations

Jacopo Francesco Imberti, Davide Antonio Mei, Marco Vitolo, Niccolò Bonini, Marco Proietti, Tatjana Potpara, Professor Gregory Lip, Giuseppe Boriani

Article2016

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

Marco Proietti, Keitaro Senoo, Deirdre A. Lane, Professor Gregory Lip

Article2017

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Professor Gregory Lip, Francisco Marı́n

Article2023

Genetic risk, modifiable risk factors, and atrial fibrillation in the Danish diet, cancer, and health cohort

Tanja Charlotte Frederiksen, Morten Krogh Christiansen, Emelia Benjamin, Kim Overvad, Anja Olsen, Niels Grarup, Mie Andersen, Torben Hansen, Henrik Kjærulf Jensen, Christina C. Dahm

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

Discussion(0)

Related publications

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

Genetic risk, modifiable risk factors, and atrial fibrillation in the Danish diet, cancer, and health cohort